Obtain results after 18 hours with no need for re-incubation of negatives using Thermo Scientific™ Brilliance™ MRSA 2 Agar. Rapidly eliminate negative results and target colonized patients for isolation and appropriate treatment as early as possible.

Brilliance MRSA 2 Agar has been enhanced over that of the original formulation in two ways. New inhibitory components in the medium inhibit the growth of more non-target organisms.

In addition, those organisms that do grow are more easily distinguished from distinctive blue MRSA colonies, through inclusion of a novel pink counter-stain, further improving ease of interpretation.

Brilliance MRSA 2 Agar has been refined to give larger MRSA colonies a more consistent color than the previous formulation.

The improved recovery of MRSA, together with the increased selectivity, makes the new Brilliance MRSA 2 Agar an invaluable and efficient tool in the implementation of infection control.

• Brilliance MRSA 2 Agar can be inoculated from a screening swab taken from hospital patient or staff, from an isolated colony or from a liquid suspension.
• MRSA grows as blue colonies which are very easy to read against the light colored, opaque background.
• Plates are incubated at 37ºC, and provide high sensitivity and specificity, with results available in just 18 hours. This allows a rapid response, so enabling the patient to receive the most appropriate treatment as early as possible, reducing the risk of onward transmission of infection.
• Accuracy minimizes costs by helping to ensure that only those in need receive what can be costly treatment.

Obtain results after 18 hours with no need for re-incubation of negatives using Thermo Scientific™ Brilliance™ MRSA 2 Agar. Rapidly eliminate negative results and target colonized patients for isolation and appropriate treatment as early as possible.

Brilliance MRSA 2 Agar has been enhanced over that of the original formulation in two ways. New inhibitory components in the medium inhibit the growth of more non-target organisms.

In addition, those organisms that do grow are more easily distinguished from distinctive blue MRSA colonies, through inclusion of a novel pink counter-stain, further improving ease of interpretation.

Brilliance MRSA 2 Agar has been refined to give larger MRSA colonies a more consistent color than the previous formulation.

The improved recovery of MRSA, together with the increased selectivity, makes the new Brilliance MRSA 2 Agar an invaluable and efficient tool in the implementation of infection control.

• Brilliance MRSA 2 Agar can be inoculated from a screening swab taken from hospital patient or staff, from an isolated colony or from a liquid suspension.
• MRSA grows as blue colonies which are very easy to read against the light colored, opaque background.
• Plates are incubated at 37ºC, and provide high sensitivity and specificity, with results available in just 18 hours. This allows a rapid response, so enabling the patient to receive the most appropriate treatment as early as possible, reducing the risk of onward transmission of infection.
• Accuracy minimizes costs by helping to ensure that only those in need receive what can be costly treatment.